Hepatitis B Envelope Antigen in Children and Adults with Hepatitis B Infection in Tertiary Health Facility in North East Nigeria During the Period 2000-2015

Introduction: Worldwide, most people living with chronic HBV infection are in in low- and middle-income countries. Most of the burden of disease from HBV infection comes from infections acquired before the age of 5 years. Materials and Methods: Records of Hepatitis B surface and envelope antigen results of children and adults in Federal Teaching Hospital, Gombe between May 2000 and May 2015 were analyzed Results: 22,862 individuals were tested for Hepatitis B surface antigen. 19.5% (4456) tested positive. 24.7 % (3146) and 12.9% (1310) of males and females respectively were HBsAg positive. HBsAg Peak prevalence of 21.8% was in the age group 26-46 (2533) and the lowest prevalence in infancy (3.5%). Amongst males, the 19-25year age group had the peak prevalence of 28.6% and in females the age group 5-9 years constituted the highest (20.3%). 36% (1602/4456) of HBsAg positive children and adults were tested for HBeAg. 26.2% (420/1602) of individuals with HBsAg carriage were HBeAg. More males (307/1105) than females (113/495) were HBeAg positive but not statistically significant. (P=0.034). Prevalence of HBeAg was highest in infants (50%) and children 1-4 years (50%) age group and thereafter declined with increasing age. Females of the younger age group <1year, 1-4 years and 5-9 years and older age group, 56-65 and >65 years, compared to their male carriers of HBsAg had higher prevalence of HBeAg but these were not statistically significant. Conclusion: A fifth of HBsAg carriers were HBeAg positive and HBeAg positivity decreased with increasing age. Hepatitis B vaccination in Nigeria requires urgent strengthening.

[1]  M. Al-Mendalawi Serological screening of hepatitis B virus and hepatitis C virus among patients attending a tertiary hospital in Jalingo, Taraba state, Nigeria , 2019, Saudi Journal for Health Sciences.

[2]  A. Geretti,et al.  Epidemiology of hepatitis B, C and D in Malawi: systematic review , 2018, BMC Infectious Diseases.

[3]  U. d’Alessandro,et al.  Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa. , 2018, Journal of hepatology.

[4]  E. Kashibu,et al.  Serological screening of hepatitis B virus and hepatitis C virus among patients attending a tertiary hospital in Jalingo, Taraba state, Nigeria , 2018 .

[5]  K. Jacobsen,et al.  Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012–2013 , 2018, BMC Research Notes.

[6]  J. Bigna,et al.  Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis , 2017, BMJ Open.

[7]  P. Kaleebu,et al.  Hepatitis B serological markers and plasma DNA concentrations , 2017, AIDS.

[8]  O. E. Ifeanyi,et al.  Evaluation of Some Immunological andHaematological Indices of Hepatitis B Infected Subjects in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Anambra State, Nigeria , 2017 .

[9]  A. Olayinka,et al.  Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey. , 2016, The American journal of tropical medicine and hygiene.

[10]  A. Kramvis The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics , 2016, Reviews in medical virology.

[11]  E. Udoh,et al.  The prevalence of hepatitis B virus infection in Nigerian children prior to vaccine introduction into the National Programme on Immunization schedule , 2016, The Pan African medical journal.

[12]  R. Ofori-Asenso,et al.  Hepatitis B in Ghana: a systematic review & meta-analysis of prevalence studies (1995-2015) , 2016, BMC Infectious Diseases.

[13]  J. Ndako,et al.  Studies on the Serological Markers of Hepatitis B Virus Infection among Children in Riyom LGA, North Central Nigeria. , 2016 .

[14]  P. Rosenthal,et al.  Children with Chronic Hepatitis B in the United States and Canada. , 2015, The Journal of pediatrics.

[15]  A. Ikefuna,et al.  Seroprevalence and Risk Factors of Hepatitis B Virus Infection among Adolescents in Enugu, Nigeria. , 2015, Journal of tropical pediatrics.

[16]  E. Sagnelli,et al.  Hepatitis B virus burden in developing countries. , 2015, World journal of gastroenterology.

[17]  B. Cowie,et al.  Estimating the global prevalence of hepatitis B , 2015, The Lancet.

[18]  T. Tamekloe,et al.  Prevalence of the Surface Antigen of Hepatitis B Virus among Youth Aged 15 to 24 in TOGO in 2010 , 2015 .

[19]  H. Whittle,et al.  Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia , 2015, Gut.

[20]  S. Asuke,et al.  Seroprevalence of Hepatitis B Infection among out Patients Attending a Public Tertiary Hospital in Kaduna State, Nigeria , 2015 .

[21]  S. Bussell,et al.  Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: a systematic review and meta-analysis. , 2015, Nigerian journal of clinical practice.

[22]  K. Ravikumar,et al.  Profi le of Hepatitis B ‘e’ Antigen and Antibodies to Hepatitis B ‘e’ Antigen in Hepatitis B Seropositive Patients at a Tertiary Care Hospital in Bengaluru, India , 2015 .

[23]  Ella,et al.  Prevalence of Hepatitis B surface antigen (HbsAg) among pregnant women attending University Health Services (sick-bay) A.B.U. Zaria , 2015 .

[24]  N. Uleanya,et al.  Prevalence and risk factors of hepatitis B virus transmission among children in Enugu, Nigeria , 2015 .

[25]  A. Ofili,et al.  Hepatitis B infection among Nigerian children admitted to a children's emergency room. , 2014, African health sciences.

[26]  E. Donbraye,et al.  Prevalence of asymptomatic hepatitis B virus surface antigenemia in children in Ilesha, Osun state, South-Western Nigeria , 2014 .

[27]  C. Bottomley,et al.  The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children , 2014, BMC Public Health.

[28]  A. Ike,et al.  Hepatitis B Virus (HBV) Serological Patterns in Benue State, Nigeria , 2014 .

[29]  M. Mutocheluh,et al.  The prevalence of hepatitis B virus E antigen among Ghanaian blood donors , 2014, The Pan African medical journal.

[30]  B. Jibrin,et al.  Prevalence of Hepatitis B surface antigen in children with sickle cell anemia , 2014 .

[31]  O. Simidele,et al.  PREVALENCE OF HBeAg AMONG HEPATITIS B SEROPOSITIVE INDIVIDUALS IN MAKURDI , NIGERIA , 2014 .

[32]  F. Bathaix,et al.  Prevalence of hepatitis B infection and factors associated in children of Ivorian HBsAg carrier subjects , 2013 .

[33]  A. Hall,et al.  Association of Early Age at Establishment of Chronic Hepatitis B Infection with Persistent Viral Replication, Liver Cirrhosis and Hepatocellular Carcinoma: A Systematic Review , 2013, PloS one.

[34]  M. A. Isa,et al.  Prevalence of serological markers for acute hepatitis B virus among patients attending Sokoto specialist hospital , Sokoto , Nigeria , 2013 .

[35]  Nigeria. Sero-epidemiological survey of hepatitis B surface antigenaemia in children and adolescents in Ekiti State, Nigeria , 2013 .

[36]  J. Forbi,et al.  Prevalence of Hepatitis B e Antigen in Chronic HBV Carriers in North-central Nigeria , 2012, Journal of health, population, and nutrition.

[37]  Gretchen A. Stevens,et al.  The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions , 2012, BMC Infectious Diseases.

[38]  O. Oshinaike,et al.  Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria , 2012, BMC Research Notes.

[39]  Amuta Eu SEROPREVALENCE OF HEPATITIS B AMONG HOSPITAL PATIENTS IN MAKURDI METROPOLIS, BENUE STATE, NIGERIA , 2012 .

[40]  C. Obirikorang,et al.  Sero-prevalence of hepatitis B surface (HBsAg) antigen in three densely populated communities in Kumasi, Ghana , 2012 .

[41]  I. Yakasai,et al.  Sero-prevalence of Hepatitis B Virus Infection and its Risk factors among Pregnant Women Attending Antenatal Clinic at Aminu Kano Teaching Hospital, Kano, Nigeria , 2012 .

[42]  H. Hsu,et al.  Long‐term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[43]  Ding‐Shinn Chen,et al.  Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters. , 2011, Gastroenterology.

[44]  S. Hadziyannis Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. , 2011, Journal of hepatology.

[45]  R. Merrill,et al.  Seroprevalence of markers for hepatitis B viral infection. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[46]  S. Zucoloto,et al.  Clinical, demographic and epidemiological characteristics of patients with hepatitis B followed at a university hospital in southeastern Brazil: predominance of HBeAg negative cases. , 2011, Revista da Sociedade Brasileira de Medicina Tropical.

[47]  A. Froment,et al.  Hepatitis B and C Virus Infections in the Three Pygmy Groups in Cameroon , 2010, Journal of Clinical Microbiology.

[48]  E. Mbaawuaga,et al.  Hepatitis B Virus (HBV) Infection among Pregnant Women in Makurdi, Nigeria. , 2010 .

[49]  C. Chu,et al.  Age‐specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B , 2010, Hepatology.

[50]  Shuhan Sun,et al.  An altered pattern of liver apolipoprotein A-I isoforms is implicated in male chronic hepatitis B progression. , 2010, Journal of proteome research.

[51]  C. Ijoma,et al.  Low Prevalence Of Hepatitis B ‘E’ Antigen In Asymptomatic Adult Subjects With Hepatitis B Virus Infection In Enugu, South East Nigeria , 2009 .

[52]  G. Odaibo,et al.  Pitfalls in diagnosis of hepatitis B virus infection among adults Nigerians. , 2009, Nigerian journal of clinical practice.

[53]  B. McMahon,et al.  The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B , 2009, Hepatology international.

[54]  M. Kehinde,et al.  Prevalence of the Hepatitis B “e” Antigen in Nigerian Patients with Chronic Liver Disease , 2008 .

[55]  H. Whittle,et al.  Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia , 2008, Virology Journal.

[56]  M. Kew,et al.  Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[57]  C. Chu,et al.  Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion , 2007, Journal of viral hepatitis.

[58]  P. Loehrer,et al.  Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level , 2007 .

[59]  Guan-Tarn Huang,et al.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.

[60]  G. Leroux-Roels,et al.  Hepatitis B virus and human immunodeficiency virus co‐infection in sub‐Saharan Africa: a call for further investigation , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[61]  J. Otegbayo,et al.  Prevalence of hepatitis B surface and e antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria. , 2003, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[62]  Tigran Nikoghosyan,et al.  United Nations Children’s Fund (UNICEF) , 2018, Yearbook of International Cooperation on Environment and Development 1998–99.

[63]  Ding‐Shinn Chen,et al.  Hepatitis B Virus Infection , 2007 .

[64]  David J Weber,et al.  Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. , 1998, American journal of epidemiology.

[65]  J. Changalucha,et al.  Sexual Transmission of Hepatitis B in Mwanza, Tanzania , 1997, Sexually transmitted diseases.

[66]  J. Adewuyi,et al.  Hepatitis B surface antigenaemia in Ilorin, Kwara State, Nigeria. , 1996, The Central African journal of medicine.

[67]  A. Olomu,et al.  The prevalence of hepatitis Be antigen and anti-HBE in adults in Benin City. , 1994, West African journal of medicine.

[68]  H. Hsu,et al.  Horizontal Transmission of Hepatitis B Virus in Children , 1993, Journal of pediatric gastroenterology and nutrition.

[69]  U. Amazigo,et al.  Hepatitis-B virus infection in rural and urban populations of eastern Nigeria: prevalence of serological markers. , 1990, East African medical journal.

[70]  B. Yvonnet,et al.  Age‐ and sex‐related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal) , 1987, Journal of medical virology.

[71]  H. Whittle,et al.  HEPATITIS B VIRUS INFECTION IN TWO GAMBIAN VILLAGES , 1983, The Lancet.